Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12617001611314
Ethics application status
Approved
Date submitted
8/11/2017
Date registered
8/12/2017
Date last updated
21/01/2020
Date data sharing statement initially provided
21/01/2020
Date results provided
21/01/2020
Type of registration
Retrospectively registered

Titles & IDs
Public title
D-tape for hip pain, does it work?
Scientific title
Comparative Sports Taping for Pain Relief and Gait Correction in Women with Greater Trochanteric Pain Syndrome
Secondary ID [1] 290428 0
Nil
Universal Trial Number (UTN)
U1111-1189-2604
Trial acronym
D'Tape
Linked study record
N/A

Health condition
Health condition(s) or problem(s) studied:
Gluteal tendinopathy 300770 0
Hip bursitis 300771 0
Lateral hip pain 300772 0
Greater trochanteric pain syndrome 300773 0
Condition category
Condition code
Musculoskeletal 300608 300608 0 0
Other muscular and skeletal disorders

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
This is a non-drug trial. Participants will have Dynamic tape (TM) - a form of elastic sports tape, applied to the side of their painful hip. The tape will be applied by a final year physiotherapy student specifically trained to do this, under the supervision of a physiotherapist with 30 yrs experience, and three degrees.
The tape will be applied twice in the same day using an identical pattern, but with a difference in stretch application. The order of application will be randomly assigned.
One application will be with no stretch applied, and the alternative application is with the recommended amount of stretch of 25% applied.
The first application will follow the base line gait assessment, and will be in place for about 20 minutes while the participant undertakes a second gait assessment. The second application will follow a washout period. The washout period is 25 minutes in duration and includes ascending and descending 25 steps. The participant will then immediately undertake a third gait assessment. The participant will then leave the second application on for up to 7 days. (Please see below)
Immediately after each tape application, the participant will be asked to walk approximately 300m. During walking their movement will be captured using a VICOM motion capture system.
Following the second tape application and gait assessment the participant will be invited to leave the tape in place for up to one week. At the end of that week the student will call the participant to ask for an average pain rating.
The study will be conducted in a university health research setting.


After each application, the participant will be asked to walk approximately 300m. During walking their movement will be captured using a VICOM motion capture system.

The final application of tape will be left on for one week. At the end of that week the student will call the participant to ask for an average pain rating.
The study will be conducted in a university health research setting.

Adherence to tape application will be monitored during the gait assessment. At the end of the follow up period the student will ask the participant how long they left the tape in place for.
Intervention code [1] 296272 0
Treatment: Devices
Comparator / control treatment
Participants will act as their own controls. They will walk once to establish a base line, and one trial with the tape on in an unstretched manner, and the second trial with the tape applied as per the manufacturers' instructions. The three walking trials will be compared with each other.

The tape application without stretch is considered a placebo intervention.
Control group
Placebo

Outcomes
Primary outcome [1] 300023 0
Adduction moment during normal gait at a brisk self-selected speed via the Vicon motion capture system.

The Vicon motion capture system measures joint movement via light reflective markers attached to pre-determined anatomy on a person, and cameras. The gait laboratory has a force plate in the floor. By combining the information from the light reflective markers and the force plate, hip adduction moment can be calculated.

Timepoint [1] 300023 0
The primary outcome will be collected on one day, with three time points within a one hour window.
1. Base line walking - with not tape applied
2. Walking with trial one tape
3. Walking with trial two tape

Secondary outcome [1] 328818 0
Pain, as measured by numeric rating scale (NRS)
Timepoint [1] 328818 0
Pain data will be collected on the day of gait assessment: Prior to the baseline walking assessment (no tape applied), immediately following each of the trail of tape application, and once one week post gait assessment
Secondary outcome [2] 328819 0
VISA-G score
This is a severity score specially designed for people with hip tendon pain.
Timepoint [2] 328819 0
This will be assessed prior to any gait assessment.
Secondary outcome [3] 328820 0
The "Assessment of quality of life" (AQoL6D) is avalidated standardised self assessment tool to evaluate an individual's quality of life.

https://www.aqol.com.au/
Timepoint [3] 328820 0
This will be assessed prior to any gait assessment.

Eligibility
Key inclusion criteria
Minimum 3 month history of greater trochanteric pain syndrome (pain on the lateral side of the hip, pain on palpation of the greater trochanter).
A average pain score of greater then 2 on an 11 point scale on most days for the preceding week.
Pain on the lateral side of the hip, pain on palpation of the greater trochanter and a positive result to one or more of the FABER (flexion, abduction, external rotation) test, the single leg stance test or the resisted FADER (flexion, adduction, external rotation) test.
Minimum age
18 Years
Maximum age
No limit
Sex
Females
Can healthy volunteers participate?
No
Key exclusion criteria
Low back pain of more then 2 on an 11 point scale on most days for the preceding week.
Pain referral pattern continuous from the lumbar spine into the buttocks, thigh or leg.
Lumbar radiculopathy
Systemic inflammatory disease
Neurological disease, e.g. Parkinson's disease
Bone cancer
People who are unable to provide informed consent in English.
Groin pain reproduction with medial rotation or the FABER test
If the ultrasound finds no evidence of gluteal tendinopathy.
Anyone allergic to sports tape.

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
All participants will act as their own control. The order of tape application will be determined by a toss of the coin by researcher AF. The result of the coin toss will known only to the person applying the tape.

The allocation will be done on the day of testing, thus recruitment into the study and allocation is concealed.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Toss of the coin
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s

The people assessing the outcomes
The people analysing the results/data
Intervention assignment
Crossover
Other design features
Participants will act as their own controls. With participants walking once to establish a base line, once with tape applied with no stretch, and once with tape applied with industry recommended stretch.
The tape applied in a non-stretch manner will act as a sham treatment. The order of the application of the tape will be randomised.
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis
Gait analysis changes will be analysed using a repeated measures ANOVA.
Pain level post gait analysis will be analysed using a student t-test.

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
ACT,NSW

Funding & Sponsors
Funding source category [1] 294832 0
Commercial sector/Industry
Name [1] 294832 0
Industry support from Dynamic Tape
Country [1] 294832 0
Australia
Primary sponsor type
University
Name
University of Canberra
Address
University Drive,
Bruce, 2606, ACT
Country
Australia
Secondary sponsor category [1] 293674 0
None
Name [1] 293674 0
None
Address [1] 293674 0
None
Country [1] 293674 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 296233 0
University of Canberra Human Research Ethics Committee
Ethics committee address [1] 296233 0
Ethics committee country [1] 296233 0
Australia
Date submitted for ethics approval [1] 296233 0
31/10/2016
Approval date [1] 296233 0
11/11/2016
Ethics approval number [1] 296233 0
16-232

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 70054 0
Dr Angie fearon
Address 70054 0
Building 12, Level D, Room 41
Discipline of Physiotherapy
Faculty of Health
University of Canberra,
University Drive,
Bruce, ACT, 2606
Country 70054 0
Australia
Phone 70054 0
+61 2 6206 8717
Fax 70054 0
Email 70054 0
Angie.Fearon@canberra.edu.au
Contact person for public queries
Name 70055 0
Angie Fearon
Address 70055 0
Building 12, Level D, Room 41
Discipline of Physiotherapy
Faculty of Health
University of Canberra,
University Drive,
Bruce, ACT, 2606
Country 70055 0
Australia
Phone 70055 0
+61 2 6206 8717
Fax 70055 0
Email 70055 0
Angie.Fearon@canberra.edu.au
Contact person for scientific queries
Name 70056 0
Angie Fearon
Address 70056 0
Building 12, Level D, Room 41
Discipline of Physiotherapy
Faculty of Health
University of Canberra,
University Drive,
Bruce, ACT, 2606
Country 70056 0
Australia
Phone 70056 0
+61 2 62068717
Fax 70056 0
Email 70056 0
Angie.Fearon@canberra.edu.au

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No/undecided IPD sharing reason/comment


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
SourceTitleYear of PublicationDOI
EmbaseDoes Dynamic Tape change the walking biomechanics of women with greater trochanteric pain syndrome? A blinded randomised controlled crossover trial.2019https://dx.doi.org/10.1016/j.gaitpost.2019.02.031
N.B. These documents automatically identified may not have been verified by the study sponsor.